Company Filing History:
1 out of 1 
1 out of 30 
Years Active: 2023
Title: Matthias Schaier: Innovator in Immunosuppression Therapy
Introduction
Matthias Schaier is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of immunosuppression therapy, particularly in the context of organ transplantation. His innovative work has the potential to improve the outcomes for patients undergoing such procedures.
Latest Patents
Matthias Schaier holds a patent for "MIC therapy for specific immunosuppression in transplantation." This invention relates to pharmaceutical compositions that utilize isolated and treated whole blood cells or Peripheral Blood Mononuclear Cells (PBMCs). These compositions are designed for the prevention and/or treatment of organ or cell graft rejection in human graft recipients. His patent represents a significant advancement in the field of transplantation medicine.
Career Highlights
Throughout his career, Matthias has worked with prominent organizations, including Tolerogenixx GmbH and Universität Heidelberg. His roles in these institutions have allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Matthias has collaborated with notable colleagues such as Christian Morath and Anita Schmitt. These partnerships have further enriched his research and development efforts in immunosuppression therapies.
Conclusion
Matthias Schaier's innovative contributions to immunosuppression therapy highlight his commitment to advancing medical science. His work has the potential to significantly impact the field of transplantation and improve patient outcomes.